EMG
CYTK icon

ETF Managers Group’s Cytokinetics CYTK Stock Holding History

ETF Managers Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,607
Closed -$273K – 727
2022
Q2 		$273K Buy
+5,607
New +$226K 0.01% 613
2022
Q1 		– Sell
-8,468
Closed -$386K – 715
2021
Q4 		$386K Buy
+8,468
New +$327K 0.01% 561

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

ETF Managers Group's CYTK Position: Q3 2022 in Review

ETF Managers Group sold out of Cytokinetics (CYTK) in Q3 2022, closing a stake of 5,607 shares — an estimated $273K sold.

ETF Managers Group first reported a position in CYTK in Q4 2021 and held it in 2 quarters. The position peaked at $386K in Q4 2021. 276 funds tracked by Wall St. Rank hold CYTK as of Q3 2022.

  • ETF Managers Group reported no remaining Cytokinetics position as of Q3 2022 after selling out during the quarter.
  • ETF Managers Group sold 5,607 Cytokinetics shares in Q3 2022, an estimated $273K.
  • ETF Managers Group first reported a position in Cytokinetics in Q4 2021 and held it in 2 quarters.
  • ETF Managers Group's Cytokinetics position peaked at $386K in Q4 2021.
  • 276 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2022.

Based on ETF Managers Group's 13F filing for Q3 2022, filed 14 Nov 2022.